Chronic Kidney Disease

The AJMC® Chronic Kidney Disease compendium is a comprehensive resource for clinical news and expert insights on the condition and treatment of loss of kidney function.

Latest News

The investigators concluded that epidemiological inequity in CKD and cardiovascular disease remains an important issue that requires further study of potential interventions. | Image credit: filins - stock.adobe.com
Disparities in CKD-Associated Cardiac Arrest Across Demographics

March 22nd 2025

Non-Hispanic Black populations face the highest risk of death from chronic kidney disease (CKD)–associated cardiac arrest, a study found.

Naz Urooj | Image credit: Interwell Health
Contributor: Data, Education, and Community: The Winning Formula for Addressing SDOH for Kidney Care Patients

March 21st 2025

Image Credit: selote - stock.adobe.com
New Guideline Updates to Slow CKD Progression and Reduce Cardiovascular Risk

March 10th 2025

Doctor holding card that says furosemide | Image credit: MQ-Illustrations – stock.adobe.com
FDA Expands Furosemide Injection Label to Treat Edema in CKD

March 7th 2025

Yo-Yo Dieting | Image Credit: © Karen Roach-stock.adobe.com
Weight Fluctuation Threatens Kidney Health in Type 1 Diabetes

February 4th 2025

Population Health Management of Chronic Kidney Disease (CKD)

An expert panel discusses chronic kidney disease (CKD), its impact on cardiovascular disease, and the methods of treatment used on the patient populations.

Panel members

More News

Kidneys
July 15th 2022

Bidirectional Association Found Between Glaucoma, CKD

Julia Bonavitacola
A systematic review found that there was a bidirectional relationship between glaucoma and chronic kidney disease (CKD), especially in participants of East Asian descent.
Kidneys
July 12th 2022

Diet Therapy Can Improve Renal Function in Patients With CKD

Julia Bonavitacola
A randomized, controlled, nonblinded trial found that nutritional treatment with supportive education could help improve renal function in patients with chronic kidney disease (CKD).
Kidneys
July 3rd 2022

Top 2% of Genome-Wide Polygenic Score Indicates 3 Times the Risk of CKD

Julia Bonavitacola
A new genome-wide polygenic score was able to determine the risk of chronic kidney disease (CKD) in patients with a score in the top 2%.
Kidney disease.
June 29th 2022

Value-Based Frameworks Can Help Transform Kidney Care Delivery

Matthew Gavidia
The utility of value-based frameworks for payers, providers, and those involved in kidney care delivery was addressed during a session at AHIP 2022.
Kidneys
June 25th 2022

Patients With CKD Avoid Thinking About Disease, According to Study

Julia Bonavitacola
A qualitative study found that patients with chronic kidney disease (CKD) were more likely to avoid thinking about their disease because of the stress from dialysis.
What We're Reading
June 22nd 2022

What We’re Reading: FDA to Cut Nicotine Levels; Insulin Pricing Bill; DaVita Loses Dialysis Case

AJMC Staff
The FDA plans to set a maximum nicotine level in cigarettes and tobacco products to reduce addictiveness; a bipartisan bill would place a $35 monthly cap on insulin for patients with private insurance or Medicare; the Supreme Court ruled that an Ohio hospital’s employee health plan did not violate federal law by limiting coverage for outpatient dialysis.
Kidneys
June 21st 2022

ESA Usage Associated With Malignancy in Patients With CKD

Julia Bonavitacola
An observational study found that erythropoiesis-stimulating agent (ESA) usage was associated with increased risk of malignancies in patients with chronic kidney disease (CKD) or end-stage renal disease.
Kidneys
June 14th 2022

Study Finds Sodium-Glucose Cotransporter 2 Inhibitors Associated With Reduced Risk of CKD

Julia Bonavitacola
A retrospective cohort study found that sodium-glucose cotransporter 2 inhibitors were associated with a reduced risk of chronic kidney disease (CKD) in adults with type 2 diabetes.
Study Finds Machine Learning Effective in Evaluating CKD Prognosis
June 7th 2022

Study Finds Machine Learning Effective in Evaluating CKD Prognosis

Julia Bonavitacola
A retrospective study found that 3 machine learning models demonstrated equivalent predictability and greater sensitivity in the prognosis of chronic kidney disease (CKD) compared with the Kidney Failure Risk Equation.
Compared With Primary Care ACOs, ESRD Model Excelled in First Year
June 6th 2022

Compared With Primary Care ACOs, ESRD Model Excelled in First Year

Julia Bonavitacola
A study found that patients in the Comprehensive End-Stage Renal Disease (ESRD) Care Model saw a decrease in hospitalizations and readmissions compared with the accountable care organization (ACO) model.
Early Detection in Minority Groups Could Help With Pediatric CKD
June 4th 2022

Early Detection in Minority Groups Could Help With Pediatric CKD

Julia Bonavitacola
Early detection of chronic kidney disease (CKD) in adolescents in minority groups can be beneficial to future treatment, according to a recent editorial.
Kidneys
June 1st 2022

CKD, Recent Transplant May Increase Cancer Risk, Study Finds

Julia Bonavitacola
A population-based cohort study found that patients with chronic kidney disease (CKD) or who underwent a recent kidney transplant had a higher risk of cancer compared with people with normal kidney function.
Study Finds Albuminuria Associated With Cognitive Decline, Increased Risk of Dementia
May 25th 2022

Study Finds Albuminuria Associated With Cognitive Decline, Increased Risk of Dementia

Julia Bonavitacola
A longitudinal cohort study found that mild albuminuria was associated with cognitive decline, worse baseline cognitive function, and increased risk of incident cognitive impairment and dementia.
GFR, ABI, High Blood Pressure Associated With Poor Prognosis in Patients With CKD
May 23rd 2022

GFR, ABI, High Blood Pressure Associated With Poor Prognosis in Patients With CKD

Julia Bonavitacola
A recent study found that patients with chronic kidney disease (CKD) had a poor prognosis based on glomerular filtration rate (GFR), ankle-brachial index (ABI), and high systolic blood pressure in a 16-week exercise program.
Site Logo
May 23rd 2022

Glucose-Lowering Treatment Patterns in Patients With Diabetic Kidney Disease

Neeraj N. Iyer, PhD Qian Li, PhD Surbhi Shah, PhD Michael L. Ganz, PhD, MS Tam Dang-Tan, PhD Cory Gamble, DO Sherif Mehanna, MD George Bakris, MD
Real-world treatment of diabetic kidney disease in the United States, based on national-level health care claims and electronic health records data, is inconsistent with the current guidelines.
doctor taking notes while talking to a patient
May 17th 2022

Contributor: Physician-Health Plan Collaboration Is Key to Early Identification of Chronic Kidney Disease

Rehan Waheed, MD
By predicting which individuals are most likely to require therapies for chronic kidney disease within the next year, health plans can better organize resource allocation to smooth or delay the transition for the patient, according to Rehan Waheed, MD of Quest Diagnostics.
Protein Biomarkers May Indicate Early Kidney Impairment, Study Finds
May 17th 2022

Protein Biomarkers May Indicate Early Kidney Impairment, Study Finds

Julia Bonavitacola
A cross-sectional analysis found that protein biomarkers were associated with estimated glomerular filtration rate, which may capture early kidney impairment.
kidneys
May 12th 2022

Mortality Rate for MI, PE, Stroke Decreased in Patients on Dialysis

Julia Bonavitacola
A cohort study found that patients receiving dialysis had decreased mortality rates over time from myocardial infarction (MI), stroke, and pulmonary embolism (PE) compared with the general population.
Study Finds Particulate Matter Exposure Associated With Incident CKD
May 12th 2022

Study Finds Particulate Matter Exposure Associated With Incident CKD

Julia Bonavitacola
A study conducted in China found that long-term exposure to ambient particulate matter increased the risk of chronic kidney disease (CKD).
Kidneys
May 8th 2022

Higher Mortality Risk Linked to ESRD Requiring LVAD Implantation in New Study

Julia Bonavitacola
A study found that patients with end stage renal/kidney disease (ESRD) who undergo left ventricular assist device (LVAD) implantation had higher 1-year mortality compared with patients with chronic kidney disease.
Pills
May 5th 2022

Dapagliflozin Meets Primary End Point in Phase 3 Trial, Reduces Risk of Cardiovascular Death and Worsening Heart Failure

Julia Bonavitacola
A phase 3 trial for dapagliflozin finds that the SGLT2 inhibitor is effective in reducing the risk of cardiovascular death and worsening heart failure in patients with preserved ejection fraction.
Image of a doctor comforting a patient
May 2nd 2022

Provider Awareness, Systematic Referral Processes May Help Peer Support Uptake in CKD

Rose McNulty
Peer support can be a helpful facet of chronic kidney disease (CKD) self-management, but inconsistent provider awareness and referral practices are barriers to uptake at Canadian clinics.
Digitally enhanced image of the heart
April 29th 2022

Patients With CKD Have Higher Risk of HFrEF After PCI

Rose McNulty
A recent study found chronic kidney disease (CKD) to be an independent risk factor for incident heart failure with reduced ejection fraction (HFrEF) following percutaneous coronary intervention (PCI).
Novel Internet-Based Hospital-to-Home Model for Nutritional Nursing Effective in Patients With CKD
April 23rd 2022

Novel Internet-Based Hospital-to-Home Model for Nutritional Nursing Effective in Patients With CKD

Rose McNulty
Continual nutrition modification is crucial in patients with moderate to advanced chronic kidney disease (CKD), and more interactive at-home solutions hold potential to improve nutritional nursing models after hospital discharge. 
Image of a kidney
April 21st 2022

Review Explores Glycemic Monitoring Methods in Chronic Kidney Disease

Rose McNulty
Monitoring glycemia in chronic kidney disease comes with challenges, but emerging strategies warrant more research in this patient population.
a computerized image of 2 kidneys over a watercolor background
April 16th 2022

Incremental Hemodialysis Provides Better Savings, Same Outcomes as Standard Hemodialysis

Skylar Jeremias
Researchers found that implementing an incremental schedule for hemodialysis in patients with residual kidney disease produced similar clinical outcomes and significant savings for health systems compared with hemodialysis administered on a more traditional schedule.
salt shaker
April 15th 2022

Sodium Intake Alone May Not Affect Risk of Chronic Kidney Disease, Study Finds

Rose McNulty
A recent study on Hispanics/Latinos in the United States found that lower potassium intake and higher sodium-to-potassium ratios may be more predictive of chronic kidney disease risk.
kidneys
April 9th 2022

Examining Changes in STEMI Treatment Strategies and Outcomes in CKD Over Time

Rose McNulty
Despite underrepresentation in clinical trials of acute coronary syndrome treatments, a recent study suggests treatment strategies and outcomes in chronic kidney disease patients with ST-elevation myocardial infarctions (STEMI) have improved over time.
pregnant woman holding a bottle of pills
April 8th 2022

Several Factors Contribute to Impaired Fertility in Women, Men With CKD

Skylar Jeremias
A literature review outlined the number of fertility complications that men and women with chronic kidney disease (CKD) face as well as the list of potential factors that can impact fertility and sexual functions in this population.
Site Logo
April 7th 2022

Comparison of Mortality Between Medicare Advantage and Traditional Medicare Beneficiaries With Kidney Failure

Daeho Kim, PhD Yoojin Lee, MS, MPH Shailender Swaminathan, PhD Rajnish Mehrotra, MD, MS Maricruz Rivera-Hernandez, PhD Rebecca Thorsness, PhD Kevin H. Nguyen, PhD Amal N. Trivedi, MD, MPH
The risk-adjusted 1-year mortality rate was not different between Medicare Advantage and traditional Medicare beneficiaries with kidney failure who initiated dialysis.
<12345678
...
12>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo